SARS-CoV-23 -

Kenana Al Adem1, Juliana C Ferreira1, Adrian J Villanueva1

  • 1Science Division, New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates.

Bioscience reports
|July 22, 2024
PubMed
概括

针对SARS-CoV-2的主要蛋白酶 (3CLpro) 对于开发有效的COVID-19抗病毒策略至关重要. 3CLpro的抑制剂通过防止必需的多蛋白质裂变来阻止病毒复制.